Log in to save to my catalogue

Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a ra...

Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a ra...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2600286491

Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study

About this item

Full title

Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study

Publisher

England: Elsevier Ltd

Journal title

Lancet neurology, 2021-12, Vol.20 (12), p.991-1000

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

The human cytokine erythropoietin conveys neuroprotection in animal models but has shown ambiguous results in phase 2 clinical trials in patients with optic neuritis. We assessed the safety and efficacy of erythropoietin in patients with optic neuritis as a clinically isolated syndrome in a multicentre, prospective, randomised clinical trial.
Th...

Alternative Titles

Full title

Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2600286491

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2600286491

Other Identifiers

ISSN

1474-4422

E-ISSN

1474-4465

DOI

10.1016/S1474-4422(21)00322-7

How to access this item